Mara Aspinall president of Roche's Ventana
This article was originally published in Clinica
Ventana Medical Systems, part of the Roche's group that specialises in tissue-based diagnostics, has appointed Mara Aspinall president. Ms Aspinall was most recently the founder, president and CEO of On-Q-ity, a start-up diagnostics company focused on circulating tumour cell technology. She previously worked at Genzyme for 12 years in a number of senior leadership roles.